Literature DB >> 15843677

Pegaptanib and age-related macular degeneration.

Jean-Marie Rakic, Pierre Blaise, Jean-Michel Foidart.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15843677     DOI: 10.1056/NEJM200504213521619

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

Review 1.  Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases.

Authors:  Yihai Cao
Journal:  Nat Rev Drug Discov       Date:  2010-02       Impact factor: 84.694

2.  VEGFR1-mediated pericyte ablation links VEGF and PlGF to cancer-associated retinopathy.

Authors:  Renhai Cao; Yuan Xue; Eva-Maria Hedlund; Zhaodong Zhong; Katerina Tritsaris; Barbara Tondelli; Franco Lucchini; Zhenping Zhu; Steen Dissing; Yihai Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

Review 3.  Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.

Authors:  Sharon D Solomon; Kristina Lindsley; Satyanarayana S Vedula; Magdalena G Krzystolik; Barbara S Hawkins
Journal:  Cochrane Database Syst Rev       Date:  2014-08-29

Review 4.  Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degeneration.

Authors:  S S Vedula; M G Krzystolik
Journal:  Cochrane Database Syst Rev       Date:  2008-04-16

5.  Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.

Authors:  Sharon D Solomon; Kristina Lindsley; Satyanarayana S Vedula; Magdalena G Krzystolik; Barbara S Hawkins
Journal:  Cochrane Database Syst Rev       Date:  2019-03-04

6.  CELL-SELEX: Novel perspectives of aptamer-based therapeutics.

Authors:  Ke-Tai Guo; Gerhard Ziemer; Angela Paul; Hans P Wendel
Journal:  Int J Mol Sci       Date:  2008-04-24       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.